Literature DB >> 7021276

The effects of a low-dose intravenous insulin infusion upon plasma glucose and non-esterified fatty acid levels in very obese and non-obese human subjects.

S M Bakir, R J Jarrett.   

Abstract

After an overnight fast, the effects of a 30-min low-dose intravenous insulin infusion (2.6 units/h) upon plasma glucose and non-esterified fatty acids were compared in 29 very obese patients and 17 non-obese controls. The dose of insulin was chosen so as to have its sole or predominant hypoglycaemic effect upon hepatic glucose release. The proportional fall from basal values at 30 min of both plasma glucose and non-esterified fatty acids was significantly greater in the controls and there was no difference between males and females. In the controls the fall in plasma glucose and non-esterified fatty acids was significantly and inversely correlated with the basal plasma insulin level. Neither index of insulin sensitivity was significantly related with the basal plasma insulin in the obese subjects. Weight lost in the obese subjects led to increased insulin sensitivity; in particular, the degree of change in insulin-induced non-esterified fatty acids was significantly related to the percentage change in weight. Despite their extreme degree of obesity, the distributions of basal plasma insulin levels and the indices of insulin sensitivity in the obese subjects overlapped with those of the non-obese controls.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021276     DOI: 10.1007/bf00257425

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Immunoassay of insulin with insulin antibody preciptate.

Authors:  C N HALES; P J RANDLE
Journal:  Lancet       Date:  1963-01-26       Impact factor: 79.321

2.  Indices of relative weight and obesity.

Authors:  A Keys; F Fidanza; M J Karvonen; N Kimura; H L Taylor
Journal:  J Chronic Dis       Date:  1972-07-01

Review 3.  Symposium I: hormone-fuel interactions in normal and diabetic man. The liver as site of insulin and glucagon action in normal, diabetic and obese humans.

Authors:  P Felig; J Wahren
Journal:  Isr J Med Sci       Date:  1975-06

4.  Metabolic responses to monocomponent human insulin infusions in normal subjects and patients with liver and endocrine disease.

Authors:  T E West; D Owens; P H Sönksen; M C Srivastava; C V Tompkins; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1975-11       Impact factor: 3.478

5.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

6.  The relation between insulin and adipocyte insulin receptors during treatment of human obesity.

Authors:  D Baxter; K Stanton; N R Lazarus; H Keen
Journal:  Eur J Clin Invest       Date:  1978-12       Impact factor: 4.686

7.  Diminished plasma free fatty acid clearance in obese subjects.

Authors:  P J Nestel; T Ishikawa; R B Goldrick
Journal:  Metabolism       Date:  1978-05       Impact factor: 8.694

8.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.

Authors:  L Saccà; R Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  Downregulation of insulin receptors in obese man.

Authors:  J P Wigand; W G Blackard
Journal:  Diabetes       Date:  1979-04       Impact factor: 9.461

View more
  3 in total

1.  Insulin regulation of glucose and lipid metabolism in massive obesity.

Authors:  S Del Prato; G Enzi; S Vigili de Kreutzenberg; G Lisato; A Riccio; L Maifreni; E Iori; F Zurlo; G Sergi; A Tiengo
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

2.  Assessment of proinsulin's effects on intermediary metabolism using the forearm technique in normal man.

Authors:  S N Davis; L Monti; P M Piatti; M Ansiferov; C Hetherington; M Brown; H Orskov; W Branch; C N Hales; K G Alberti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 3.  Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research.

Authors:  Amedeo Lonardo; Ayako Suzuki
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.